[Beta receptor blockers and calcium antagonists in coronary disease. Differential therapeutic aspects].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D000788:Angina Pectoris, Variant / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D006801:Humans; D008790:Metoprolol / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D010101:Oxygen Consumption / Q000187:drug effects; D010919:Placebos; D011379:Prognosis; D011433:Propranolol / Q000627:therapeutic use; D013999:Timolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D010919:Placebos; D013999:Timolol; D011433:Propranolol; D008790:Metoprolol
Beta-Rezeptorenblocker und Calciumantagonisten bei der koronaren Herzkrankheit. Differentialtherapeutische Aspekte.